Accel Wealth Management Organon & Co. Transaction History

Accel Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$23.31 - $28.61 $233 - $286	-10 Reduced 9.17%	99 $0
Q3 2022 Oct 12, 2022	SELL	$23.4 - $34.25 $351 - $513	-15 Reduced 12.1%	109 $3,000
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $31 - $38	1 Added 0.81%	124 $4,000
Q1 2022 Apr 29, 2022	SELL	$30.45 - $39.36 $1,918 - $2,479	-63 Reduced 33.87%	123 $4,000
Q4 2021 Jan 18, 2022	SELL	$28.67 - $37.13 $286 - $371	-10 Reduced 5.1%	186 $6,000
Q3 2021 Nov 04, 2021	BUY	$28.63 - $35.64 $1,832 - $2,280	64 Added 48.48%	196 $6,000
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $3,755 - $5,016	132 New	132 $4,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Accel Wealth Management with notifications on news.